EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc. (NYSE: BNT - News), a specialty pharmaceutical company focused on advanced drug delivery technologies and generic pharmaceutical products, today announced five generic product approvals from the Spanish Ministry of Health and an approval for simvastatin from the Irish Medicines Board.
